Compound News and Research

RSS

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

Manufacturers in the crowded and highly fragmented European active pharmaceutical ingredients (API) market are struggling to overcome a variety of challenges. One of the most pressing of these is the problem of overcapacity.

29 Nov 2004

Scientists have given blind nerve cells the ability to detect light

Scientists at the University of California, Berkeley, have given "blind" nerve cells the ability to detect light, paving the way for an innovative therapy that could restore sight to those who have lost it through disease.

24 Nov 2004

Topical cream alternative to Vioxx

A clinical study recently published in The Journal of Rheumatology concludes that a topical cream consisting of a blend of natural oils called cetylated fatty acids significantly increased range of motion and physical performance in patients with osteoarthritis of the knee with no reported side effects.

24 Nov 2004

Experimental compound prevents cholesterol gallstone disease

A promising experimental compound prevents cholesterol gallstone disease in mice by stimulating the biochemical pathway that controls bile acid secretion by the liver, according to new studies by Howard Hughes Medical Institute researchers.

23 Nov 2004

Cells linked to asthma and eczema also help cure deadly illness in mice

Mast cells are immune cells known mostly for their unwanted effects: they cause the wheezing of asthma, the itching of eczema, the sneezing and runny nose of hay fever and, in extreme cases, the life-threatening shock of anaphylaxis.

20 Nov 2004

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Generic antipsychotic drugs can protect brain cells from a virus that causes a fatal nervous system disorder, according to research conducted at Brown University and Case Western Reserve University.

18 Nov 2004

Eisai In-licenses Anti-hepatitis B Agent clevudine From Bukwang Pharm

Eisai Co., Ltd. announced today that the Company has in-licensed an anti-hepatitis B agent (generic name: clevudine) from Bukwang Pharm (Headquarters, Seoul, South Korea, President: Sung-Koo Lee).

16 Nov 2004

What makes beer taste so darn good to men, but vile to most women?

What makes beer taste so darn good to men, but vile to most women? Some oral sensations are under genetic control and new research suggests that these influences on taste perception could help determine the risk of excess alcohol consumption.

16 Nov 2004

Discovery of new compounds that may treat mucus build-up associated with cystic fibrosis

Preliminary studies show these compounds improve the flow of mucus through the respiratory tract, allowing airways to clear more quickly and efficiently.

14 Nov 2004

Mast cells can provide protection from a potentially deadly condition known as sepsis

14 Nov 2004

New study to determine whether natural tomato oil may reverse or delay progression of prostate cancer

Lycopene, an antioxidant commonly found in tomatoes and tomato-based products, is commonly perceived to reduce the risk of developing prostate cancer.

8 Nov 2004

Researchers have identified a protein that transports the essential nutrient boron into cells

Researchers at UT Southwestern Medical Center at Dallas have identified a protein that transports the essential nutrient boron into cells, where it is important for cell growth and bone development. The findings are in the Nov. 5 edition of the journal Molecular Cell and are online.

5 Nov 2004

Body's 'internal marijuana': A new target for treatment of schizophrenia, Parkinson's?

“Endocannabinoids” is an impressive word that sounds like the name for a group of tribal warriors or an ancient people. Actually, it is the scientific term for beneficial molecules produced in the brain that act as “a sort of internal marijuana in our system

4 Nov 2004

Psoriasis trial enters final stage

Solbec Pharmaceuticals Ltd today announced the successful completion of the first two stages of the Phase I clinical trial of its lead compound, CoramsineTM (SBP002), for the treatment of psoriasis.

4 Nov 2004

Patent litigation the most commonly used generic defense strategy among pharmaceutical companies

Patent litigation remains the most commonly used generic defense strategy among pharmaceutical companies. 71% of drug companies have used legal battles to defend their patents in the past three years, according to research from pharmaceutical business intelligence firm Cutting Edge Information.

4 Nov 2004

Wyeth shows new Phase III data about its investigational antibiotic, tigecycline

Wyeth Pharmaceuticals recently presented exciting new Phase III data about its investigational antibiotic, tigecycline, based on a clinical trial in patients with complicated intra-abdominal infections (cIAI).

4 Nov 2004

Scientists recreate Roman skin cosmetics

Cosmetic face cream used by fashionable Roman women has been analysed by scientists at Bristol University, UK, and then reproduced.

4 Nov 2004

New clues about how brain cells are damaged by Alzheimer's disease

University of Kentucky chemistry professor Allan Butterfield has uncovered new clues about how brain cells are damaged by Alzheimer's disease, evidence suggesting vitamin E may help prevent the debilitating illness.

1 Nov 2004

Patent issued for nanotechnology bone biomaterial

Competitive Technologies announced today that patent number 6,808,561 has been issued by the US Patent Office for Dr. Brian R. Genge's nanotechnology bone biomaterial developed at the University of South Carolina (USC).

1 Nov 2004

New role for a key protein involved in muscle contraction

Overturning a scientific stereotype, researchers at the University of Illinois at Chicago have discovered a new role for a key protein involved in muscle contraction and shown it is present not just in the cytoplasm of cells but in the nucleus as well.

1 Nov 2004

Compound News and Research

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

Scientists have given blind nerve cells the ability to detect light

Topical cream alternative to Vioxx

Experimental compound prevents cholesterol gallstone disease

Cells linked to asthma and eczema also help cure deadly illness in mice

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Eisai In-licenses Anti-hepatitis B Agent clevudine From Bukwang Pharm

What makes beer taste so darn good to men, but vile to most women?

Discovery of new compounds that may treat mucus build-up associated with cystic fibrosis

Mast cells can provide protection from a potentially deadly condition known as sepsis

New study to determine whether natural tomato oil may reverse or delay progression of prostate cancer

Researchers have identified a protein that transports the essential nutrient boron into cells

Body's 'internal marijuana': A new target for treatment of schizophrenia, Parkinson's?

Psoriasis trial enters final stage

Patent litigation the most commonly used generic defense strategy among pharmaceutical companies

Wyeth shows new Phase III data about its investigational antibiotic, tigecycline

Scientists recreate Roman skin cosmetics

New clues about how brain cells are damaged by Alzheimer's disease

Patent issued for nanotechnology bone biomaterial

New role for a key protein involved in muscle contraction

Advancing therapeutic biopolymer development eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News